Development of surface-functionalised nanoparticles for FGF2 receptor-based solid tumour targeting

References

• Azarmi S, Huang Y, Chen H, McQuarrie S, Abrams D, Roa W, Finlay WH, Miller GG, Löbenberg R. Optimization of a two-step desolvation method for preparing gelatin nanoparticles and cell uptake studies in 143B osteosarcoma cancer cells. J Pharm Pharm Sci 2006; 9: 124–32
   PubMed Web of Science ®Google Scholar
• Borkovec M. Measuring particle size by light scattering. Handbook of applied surface and colloid chemistry, K Holmberg. John Wiley & Sons, New York 2002; 357–70
   Google Scholar
• Cascon MG, Lazzeri L, Carmignani C, Zhu Z. Gelatin nanoparticles produced by a simple w/o emulsion as a drug delivery of methotrexate. J Mater Sci Mater Med 2002; 13: 523–6
   PubMedGoogle Scholar
• Chung Y, Tae G, Yuk SH. A facile method to prepare heparin-functionalized nanoparticles for controlled release of growth factors. Biomaterials 2006; 27: 2621–6
   PubMed Web of Science ®Google Scholar
• Coester CJ, Langer K, Briesen HV, Kreuter J. Gelatin nanoparticles by two step desolvation: A new preparation method, surface modifications and cell uptake. J Microencapsulation 2000; 17: 187–93
   PubMed Web of Science ®Google Scholar
• Dickson C, Spencer-Dene B, Dillon C, Fantl V. Tyrosine kinase signalling in breast cancer: Fibroblast growth factors and their receptors. Breast Cancer Res 2000; 2: 191–6
   PubMed Web of Science ®Google Scholar
• Elbert S, Hubbell JA. Development of fibrin derivatives for controlled release of heparin-binding growth factors. J Control Release 2000; 65: 389–402
   PubMedGoogle Scholar
• Kataoka K, Harada A, Nagasaki Y. Block copolymer micelles for drug delivery: Design, characterization and biological significance. Adv Drug Deliv Rev 2001; 47: 113–31
   PubMed Web of Science ®Google Scholar
• Konishi M, Tabatab Y, Kariya M, Hosseinkhani H, Suzuki A, Fukuhara K, Mandai M, Takakura K, Fujii S. In vivo anti-tumor effect of dual release of Cisplatin and adriamycin from biodegradable gelatin hydrogel. J Control Release 2005; 103: 7–19
   PubMed Web of Science ®Google Scholar
• Konishi M, Tabata Y, Kariya M, Suzuki A, Mandai M, Nanbu K, Takakura K, Fujii S. In vivo anti-tumor effect through the controlled release of Cisplatin from biodegradable gelatin hydrogel. J Control Release 2003; 92: 301–13
   PubMed Web of Science ®Google Scholar
• Leo E, Cameroni R, Forni F. Dynamic dialysis for the drug release evaluation from doxorubicin–gelatin nanoparticle conjugates. Int J Pharm 1999; 180: 23–30
   PubMed Web of Science ®Google Scholar
• Leo E, Vandelli MA, Cameroni R, Forni F. Doxorubicin-loaded gelatin nanoparticles stabilized by glutaraldehyde: Involvement of the drug in the cross-linking process. Int J Pharm 1997; 155: 75–82
   Web of Science ®Google Scholar
• Moffat AC, Osselton MD, Widdop B, Watts J. Clarke's analysis of drugs and poisons. Pharmaceutical Press, London 2005
   Google Scholar
• Narayami R, Rao KP. Controlled release of anticancer drug methotrexate from biodegradable gelatin microspheres. J Microencapsul 1994; 11: 69–77
   PubMedGoogle Scholar
• Oppenheim RC, Stewart NF. The manufacture and tumor cell uptake of nanoparticles labelled with fluoroscein isothiocyanate. Drug Dev Ind Pharm 1979; 5: 583–91
   Google Scholar
• Pan J, Feng SS. Targeted delivery of paclitaxel using folate-decorated poly(lactide) vitamin E TPGS nanoparticles. Biomaterials 2008; 29: 2663–72
   PubMed Web of Science ®Google Scholar
• Park K, Kim JH, Nam YS, Lee S, Nam HY, Kim K, Park JH, Kim IS, Choi K, Kim SY, et al. Effect of polymer molecular weight on the tumor targeting characteristics of self-assembled glycol chitosan nanoparticles. J Control Release 2007; 122: 305–14
   PubMed Web of Science ®Google Scholar
• Rosenberg B. Platinum complexes for the treatment of cancer. Interdiscipl Sci Rev 1978; 3: 134–47
   Web of Science ®Google Scholar
• Saul JM, Annapragada A, Natarajan JV, Bellamkonda RV. Controlled targeting of liposomal doxorubicin via the folate receptor in vitro. J Control Release 2003; 92: 49–67
   PubMed Web of Science ®Google Scholar
• Shenoy DB, Amiji MM. Poly (ethylene oxide) modified poly (caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer. Int J Pharm 2005; 293: 261–70
   PubMed Web of Science ®Google Scholar
• Storm G, Belliot SO, Daemen T, Lasic DD. Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system. Adv Drug Deliv Rev 1995; 17: 31–48
   Web of Science ®Google Scholar
• Tabata Y, Ikada Y. Synthesis of gelatin microspheres containing interferon. Pharm Res 1994; 6: 422–7
   Google Scholar
• Torchilin VP. Targeted pharmaceutical nanocarriers for cancer therapy and imaging. AAPS J 2007; 9: 128–47
   PubMed Web of Science ®Google Scholar
• Veis A. The macromolecular chemistry of gelatin. Academic Press, New York 1964
   Google Scholar
• Weber C, Coester C, Kreuter J, Langer K. Desolvation process and surface characterization of protein nanoparticles. Int J Pharm 2000; 194: 91–102
   PubMed Web of Science ®Google Scholar